Since 1997, the Brazilian national AIDS program has provided free antiretroviral therapy (cART) for individuals infected with HIV, initially for patients with a CD4+ T cell count below 350 cell/mm3 and/or with opportunistic diseases. Here, CD4 is linked to AIDS.